Literature DB >> 28244658

Nutritional, microbiological and psychosocial implications of the low FODMAP diet.

Heidi Maria Staudacher1.   

Abstract

Dietary restriction of certain fermentable carbohydrates (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet) is effective for managing symptoms of irritable bowel syndrome (IBS). However, there are potential consequences of this diet that relate to its impact on nutritional, microbiological, and health-related quality of life outcomes. Evidence suggests that the low FODMAP diet leads to some alterations in nutrient intake. For example, carbohydrate intake is reduced, and there is a decrease in the proportion of patients meeting the recommended intake for calcium. Intake of other macro and micro-nutrients appears to be adequate in the short term. As well as the impact on nutrient intake, extensive dietary modification can have a pronounced impact on the gastrointestinal microbiota. Indeed, recent data suggests the diet markedly reduces luminal Bifidobacteria concentration, and there is limited evidence that it reduces total bacteria abundance and concentration of other bacterial groups, for example, Faecalibacterium prausnitzii. Finally, despite the evidence for its clinical effectiveness in patients with IBS, the restrictive nature of the diet could pose a significant burden on patients, thereby limiting improvements, or indeed worsening health-related quality of life. In conclusion, while robust evidence supports the clinical effectiveness of the low FODMAP diet, it is important, considering the likelihood of its continued widespread use in IBS and other functional bowel disorders, that we extend our understanding of the impact of the diet on endpoints that may have potential consequences for long term health.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  FODMAP; diet; irritable bowel syndrome; microbiota; quality of life

Mesh:

Substances:

Year:  2017        PMID: 28244658     DOI: 10.1111/jgh.13688

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

2.  Dietary Intakes of Recipients of Faecal Microbiota Transplantation: An Observational Pilot Study.

Authors:  Annabel K Clancy; Christina Lee; Harrison Hamblin; Anoja W Gunaratne; Antoinette LeBusque; Eleanor J Beck; Marie V Dawson; Thomas J Borody
Journal:  Nutrients       Date:  2021-04-28       Impact factor: 5.717

3.  FODMAP Intake in Spanish Population: Open Approach for Risk Assessment.

Authors:  Jonatan Miranda; Maialen Vázquez-Polo; Gesala Pérez-Junkera; María Del Pilar Fernández-Gil; María Ángeles Bustamante; Virginia Navarro; Edurne Simón; Olaia Martínez
Journal:  Int J Environ Res Public Health       Date:  2020-08-13       Impact factor: 3.390

4.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS).

Authors:  Paul Moayyedi; Christopher N Andrews; Glenda MacQueen; Christina Korownyk; Megan Marsiglio; Lesley Graff; Brent Kvern; Adriana Lazarescu; Louis Liu; William G Paterson; Sacha Sidani; Stephen Vanner
Journal:  J Can Assoc Gastroenterol       Date:  2019-01-17

Review 5.  Review article: an analysis of safety profiles of treatments for diarrhoea-predominant irritable bowel syndrome.

Authors:  Brian E Lacy
Journal:  Aliment Pharmacol Ther       Date:  2018-09-07       Impact factor: 8.171

Review 6.  Selenium in Human Health and Gut Microflora: Bioavailability of Selenocompounds and Relationship With Diseases.

Authors:  Rannapaula Lawrynhuk Urbano Ferreira; Karine Cavalcanti Maurício Sena-Evangelista; Eduardo Pereira de Azevedo; Francisco Irochima Pinheiro; Ricardo Ney Cobucci; Lucia Fatima Campos Pedrosa
Journal:  Front Nutr       Date:  2021-06-04

Review 7.  The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome.

Authors:  Ashton Harper; Malwina M Naghibi; Davinder Garcha
Journal:  Foods       Date:  2018-01-26

Review 8.  The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge.

Authors:  Amir Mari; Fadi Abu Baker; Mahmud Mahamid; Wisam Sbeit; Tawfik Khoury
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

Review 9.  Low FODMAP Diet: Evidence, Doubts, and Hopes.

Authors:  Massimo Bellini; Sara Tonarelli; Attila G Nagy; Andrea Pancetti; Francesco Costa; Angelo Ricchiuti; Nicola de Bortoli; Marta Mosca; Santino Marchi; Alessandra Rossi
Journal:  Nutrients       Date:  2020-01-04       Impact factor: 5.717

Review 10.  Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia.

Authors:  Kerith Duncanson; Grace Burns; Jennifer Pryor; Simon Keely; Nicholas J Talley
Journal:  Nutrients       Date:  2021-03-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.